Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Toshitaka, Yajima"'
Autor:
Ryo Nakamaru, Yasuyuki Shiraishi, Takashi Kohno, Yuji Nagatomo, Hiroki Akiyama, Yuki Motoya, Masato Fukui, Toshitaka Yajima, Tsutomu Yoshikawa, Shun Kohsaka
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 692-701 (2024)
Abstract Aims The trajectories of systolic function after admission for acute heart failure (HF) and their effect on clinical outcomes have not been fully elucidated. We aimed to assess changes in left ventricular ejection fraction (LVEF) between the
Externí odkaz:
https://doaj.org/article/983301e57ed4447b918880775f066e27
Autor:
Ken-ei Sada, Shunichi Fukuhara, Hajime Yamazaki, Yosuke Yamamoto, Jui Wang, Yugo Shibagaki, Yoshihiro Onishi, Takafumi Wakita, John E Ware, Toshitaka Yajima
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Introduction Hyperkalaemia (HK) is a frequent complication in patients with chronic kidney disease (CKD) and/or chronic heart failure (CHF). HK must be managed, both to protect patients from its direct clinical adverse outcomes and to enable treatmen
Externí odkaz:
https://doaj.org/article/127a3f0c5c0e4f3386109a496d258c54
Autor:
Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, Eva Lesén, Abiy Agiro, Matthew Arnold, Gengshi Chen, Toshitaka Yajima, Krister Järbrink, Charles V. Pollack
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Hyperkalemia (HK) is a barrier to optimization of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy in heart failure (HF) and chronic kidney disease (CKD). We investigated cardiorenal risk associated with changes in R
Externí odkaz:
https://doaj.org/article/c56c6c84f9cf42459f58bb8496b50469
Autor:
Eiichiro Kanda, Atsushi Suzuki, Masaki Makino, Hiroo Tsubota, Satomi Kanemata, Koichi Shirakawa, Toshitaka Yajima
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Chronic kidney disease (CKD) and heart failure (HF) are the first and most frequent comorbidities associated with mortality risks in early-stage type 2 diabetes mellitus (T2DM). However, efficient screening and risk assessment strategies for
Externí odkaz:
https://doaj.org/article/b26f926eaa994a55987acd0a344dabad
Publikováno v:
Frontiers in Physiology, Vol 14 (2023)
Introduction: Hyperkalemia (HK) is a common disorder in patients with heart failure or chronic kidney disease, and potassium binders (PBs) are recommended to control serum potassium (S-K) levels. Although HK is often a chronic condition, short-term a
Externí odkaz:
https://doaj.org/article/8b0b3ae8fd3b4cab8ec6bf916d096792
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Cardio-renal-metabolic (CRM) syndrome, which involves type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and heart failure (HF), is a serious healthcare issue globally, with high morbidity and mortality. The disorders that comprise CRM sy
Externí odkaz:
https://doaj.org/article/5db87e54e21c42a9b6bda303392fca6f
Autor:
Shun Kohsaka, MD, Suguru Okami, PhD, Eiichiro Kanda, MD, PhD, MPH, Naoki Kashihara, MD, PhD, Toshitaka Yajima, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 2, Pp 274-285 (2021)
Objective: To examine the association between hyperkalemia and long-term cardiovascular and renal outcomes in patients with chronic kidney disease. Patients and Methods: An observational retrospective cohort study was performed using a Japanese hospi
Externí odkaz:
https://doaj.org/article/39c16e44954f46989222bb763d6d7750
Publikováno v:
Kidney International Reports, Vol 4, Iss 9, Pp 1248-1260 (2019)
Introduction: An abnormal serum potassium (S-K) level is an important electrolyte disturbance. However, its relation to clinical outcomes in real-world patients, particularly hyperkalemia burden, is not extensively studied. Methods: An observational
Externí odkaz:
https://doaj.org/article/82d259bad3b2404eab1260c5b785d840
Autor:
Shunichi Fukuhara, Hajime Yamazaki, Takafumi Wakita, John E. Ware Jr., Jui Wang, Yoshihiro Onishi, Toshitaka Yajima, Kenei Sada, Yosuke Yamamoto, Yugo Shibagaki
Publikováno v:
Annals of Clinical Epidemiology. 5:13-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd594f8c26a63a288d987e707c078f6
https://doi.org/10.37737/ace.23003
https://doi.org/10.37737/ace.23003
Publikováno v:
Folia Pharmacologica Japonica. 158:89-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72fe66e980dfa81fcc13563ce52c0074
https://doi.org/10.1254/fpj.22107
https://doi.org/10.1254/fpj.22107